STARLITE 1: Phase 1b/2 Study of Combined 177Lu-Girentuximab plus Cabozantinib and Nivolumab in Treatment-naïve Patients with Advanced Clear-cell Renal Cell Carcinoma

• DOI: 10.1016/j.euf.2025.04.003
• Publication Date: 2025-04-26T21:29:03Z
• Authors: Elshad Hasanov; Lesley Flynt; Rebecca Slack Tid...; Hyunsoo Hwang; Roserika Brooks; Lauren Michelle Wood; Travis Solley; Mashaal Syed; Aradhana M. Venka...; Eric Jonasch
• Keywords: Cabozantinib